Capsule SmartLinx Vitals Plus

Capsule’s patient monitoring system clears the FDA

Called SmartLinx Vitals Plus, the solution integrates vital signs monitoring, documentation and connectivity in a single device.
NFANT Feeding Solution

NFANT Labs’ smart infant feeding solution gets FDA clearance

The nfant Feeding Solution monitors infants' tongue movements during feeding to provide objective, measurable data, accessible from a connected mobile device.
Zensor

Intelesens’ zensor gets FDA 510(k) clearance

The small device can be worn for seven days at a time, while collecting data on respiration rate, three-lead ECG, heart rate and motion.
LifeWatch

FDA clears LifeWatch’s ACT software on Android

This clearance is part of the company's plan to introduce a universal gateway, which will also run on Android and is currently under development.
Abilify bottle

First digital medicine starts its journey with the FDA

A drug/device product combines Otsuka's ABILIFY for serious mental illness, embedded with the Proteus ingestible sensor in a single tablet to record ingestion.
Eko Core

FDA clears Eko’s digital stethoscope

Called CORE, the device can wirelessly stream heart sounds to a smartphone app and integrate heart sounds directly into the patient's electronic health record.
HealthWatch

HealthWatch’s MasterCaution Device clears the FDA hurdle

The agency cleared it as a Class II medical device intended to condition electrocardiogram (ECG) signals for digital transmission via Bluetooth.
Dexcom G5 Mobile CGM system

Dexcom G5 Mobile CGM system clears the FDA

This is the first and only full mobile CGM system that allows adults and children as young as 2 years old to conveniently monitor and share glucose levels.
GlucoTrack

Noninvasive glucose monitoring device GlucoTrack starts its regulatory journey with the FDA

The product, developed by Integrity Applications, comes in the form of a clip the user places on his or her ear to take readings without drawing blood.
precisionFDA

precisionFDA to enable genomic researchers to collaborate

The platform will enable next generation sequencing (NGS) researchers to share and cross-validate their tests/results against crowd-sourced reference material.